The Leyvi Law Group, P.C.
Objective: This study aimed to compare the risk of developing systemic autoimmune diseases (SADs) among pediatric patients with juvenile idiopathic arthritis (JIA) treated with tumor necrosis factor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results